Job/Unit: O30208
/KAP1
Date: 16-04-13 16:49:36
Pages: 14
E.-U. Würthwein et al.
FULL PAPER
7.22 (d, JH,H = 8.5 Hz, 2 H, m-CHAr), 8.12 (d, JHH = 8.2 Hz, 2 tions collected (Ϯh, Ϯk, Ϯl), [(sinθ)/λ] = 0.60 Å–1, 1852 indepen-
H, o-CHAr), 8.77 (s, 1 H, NCHN) ppm. 13C NMR (75 MHz, dent (Rint = 0.034) and 1668 observed reflections [IϾ2σ(I)], 136
CD2Cl2): δ = 20.2, 23.9 [NCH(CH3)2], 48.3 f, 49.7 [NCH(CH3)2], refined parameters, R = 0.038, wR2 = 0.101, max. (min.) residual
3
3
129.1 (m-CHAr), 130.2 (o-CHAr), 135.4 (i-CHAr), 142.6 (p-CAr),
electron density 0.12 (–0.13)eÅ–3, hydrogen atoms calculated and
158.6 (NCN), 177.6 (CO) ppm. IR (neat): ν = 3055 (vw), 3026 (w), refined as riding atoms.
˜
3003 (w), 2968 (m), 2928 (w), 2862 (w), 1682 (m), 1634 (vs), 1612
4-Methyl-N-(pyrrolidin-1-ylmethylene)benzamide (5g): Obtained
(s), 1510 (w), 1452 (w), 1414 (w), 1379 (m), 1366 (m), 1335 (vs),
1260 (vs), 1215 (w), 1186 (w), 1159 (w), 1128 (m), 1084 (vs), 1022
(w), 959 (m), 949 (w), 920 (w), 880 (w), 860 (w), 831 (s), 775 (s),
760 (m), 615 (s) cm–1. HRMS (ESI): m/z calcd. for C15H23N2O+
247.1805; found 247.1811. C15H22N2O (246.35): calcd. C 73.13, H
9.00, N 11.37; found C 73.15, H 8.09, N 11.19.
from pyrrolidine-1-carbonitrile (1a; 0.192 g, 2 mmol) and 4-meth-
ylbenzoyl chloride (0.371 g, 0.24 mmol) according to the general
procedure. Pure product 5g (0.352 g, 1.63 mmol, 81%) was ob-
tained by column chromatography (diethyl ether/n-pentane, 3:1 +
10% triethylamine) and HPLC (ethyl acetate/cyclohexane, 1:1) as
1
a colourless solid (m.p. 110 °C). H NMR (400 MHz, CD2Cl2): δ
N-[(Diisopropylamino)methylene]pivalamide (5e): Obtained from
N,N-diisopropylcyanamide (1d; 0.252 g, 2 mmol) and pivaloyl
chloride (0.289 g, 0.24 mmol) according to the general procedure.
Pure product 5e (0.430 g, 1.75 mmol, 87%) was obtained after col-
umn chromatography (diethyl ether/n-pentane, 1:5 + 10% triethyl-
amine) and HPLC (ethyl acetate/cyclohexane, 1:5) as a colourless
solid (m.p. 72 °C). 1H NMR (300 MHz, CD2Cl2): δ = 1.15 [s, 9 H,
= 1.99 (m, 4 H, NCH2CH2), 2.39 (s, 3 H, Aryl-CH3), 3.64 (m, 4
3
3
H, NCH2), 7.22 (d, JH,H = 8.2 Hz, 2 H, m-CHAr), 8.13 (d, JH,H
= 8.2 Hz, 2 H, o-CHAr), 8.77 (s, 1 H, NCHN) ppm. 13C NMR
(100 MHz, CD2Cl2): δ = 21.8 (Aryl-CH3), 25.5, 24.9 (NCH2CH2),
50.3, 46.8 (NCH2), 129.1 (m-CHAr), 130.2 (o-CHAr), 135.0 (i-CAr),
142.7 (p-CArCH ), 157.6 (NCHN), 177.6 (CO) ppm. IR (neat): ν =
˜
3
3075 (vw), 3021 (w), 2970 (m), 2922 (w), 2876 (w), 2361 (vw), 2340
(vw), 1726 (vw), 1636 (s), 1591 (vs), 1562 (vs), 1504 (m), 1472 (m),
1441 (s), 1348 (s), 1333 (s), 1304 (s), 1294 (s), 1252 (s), 1190 (s),
1173 (s), 1161 (s), 1113 (m), 1082 (s), 1040 (s), 1016 (s), 993 (s),
970 (s), 932 (s), 916 (s), 901 (s), 856 (s), 841 (s), 806 (s), 777 (s),
3
3
C(O)C(CH3)3], 1.28 (d, JH,H = 6.8 Hz, 6 H, CH3), 1.31 (d, JH,H
3
=
6.8 Hz, 6 H, CH3), 3.67 [hept, JH,H = 6.8 Hz, 1 H,
3
NCH(CH3)2], 4.38 [hept, JH,H = 6.8 Hz, 1 H, NCH(CH3)2], 8.46
(s, 1 H, NCHN) ppm. 13C NMR (75 MHz, CD2Cl2): δ = 23.9, 20.2
[NCH(CH3)2], 28.0 [C(O)C(CH3)3], 48.3, 49.7, [NCH(CH3)2], 157.7 760 (vs), 692 (s), 664 (m), 637 (s), 602 (m), 581 (m), 563 (m), 538
(NCN), 192.3 (CO) ppm. IR (neat): ν = 2994 (m), 2968 (s), 2955 (m), 528 (m), 513 (m), 500 (s), 488 (vs) cm–1. HRMS (ESI): m/z
˜
(m), 2930 (w), 2901 (w), 2870 (w), 2361 (w), 2344 (w), 1636 (s),
1568 (vs), 1549 (s), 1477 (s), 1450 (m), 1387 (vs), 1371 (vs), 1356 (216.28): calcd. C 72.19, H 7.46, N 12.95; found C 71.68, H 7.40,
calcd. for C13H17N2O+ 217.1335; found 217.1339. C13H16N2O
(s), 1331 (m), 1283 (m), 1217 (w), 1207 (m), 1180 (m), 1165 (m),
1125 (s), 1109 (vs), 1030 (m), 1016 (s), 937 (w), 924 (m), 899 (w),
883 (w), 862 (w), 820 (w), 777 (w), 741 (w), 667 (w), 604 (m), 590
(w), 559 (m) cm–1. HRMS (ESI): m/z calcd. for C12H25N2O+
213.1961; found 213.1960. C12H24N2O (212.33): calcd. C 67.88, H
11.39, N 13.19; found C 67.65, H 11.07, N 13.16.
N 12.70.
N-(Pyrrolidin-1-ylmethylene)pivalamide (5h): Obtained from pyr-
rolidine-1-carbonitrile (1a; 0.192 g, 2 mmol) and pivaloyl chloride
(0.289 g, 0.24 mmol) according to the general procedure. Pure
product 5h (0.109 g, 0.60 mmol, 30%) was obtained by column
chromatography (diethyl ether/n-pentane, 2:1 + 10% triethylamine)
and HPLC (ethyl acetate/cyclohexane, 8:1) as a colourless solid
(m.p. 61 °C). 1H NMR (300 MHz, CD2Cl2): δ = 0.94–1.11 (m, 4
N-(Pyrrolidin-1-ylmethylene)benzamide (5f): Obtained from pyrrol-
idine-1-carbonitrile (1a; 0.192 g, 2 mmol) and benzoyl chloride
(0.337 g, 0.24 mmol) according to the general procedure. Pure
product 5f (0.241 g, 1.19 mmol, 60%) was obtained by column
chromatography (diethyl ether/n-pentane, 3:1 + 10% triethylamine)
and HPLC (ethyl acetate/cyclohexane, 1:2) as a colourless solid
3
H, NCH2CH2), 1.54 [s, 9 H, C(CH3)3], 2.49 (t, JH,H = 6.7 Hz, 2
3
H, NCH2), 3.08 (t, JH,H = 9.3 Hz, 2 H, NCH2), 8.54 (s, 1 H,
NCHN) ppm. 13C NMR (75 MHz, CD2Cl2): δ = 24.9, 25.5
(NCH2CH2), 28.3 [NC(CH3)3], 41.2 [NC(CH3)3], 45.6, 48.5
1
(m.p. 69–70 °C). H NMR (400 MHz, CD2Cl2): δ = 1.95–2.01 (m,
(NCH ), 156.9 (NCHN), 191.3 (CO) ppm. IR (neat): ν = 2972 (m),
˜
2
4 H, NCH2CH2), 3.63–3.67 (m, 4 H, NCH2), 7.38–7.41 (m, 2 H, 2961 (s), 2926 (m), 2864 (m), 2361 (m), 2344 (m), 1643 (vs), 1576
m-CHAr), 7.46–7.49 (m, 1 H, p-CHAr), 8.15–8.31 (m, 2 H, o-CHAr), (vs), 1553 (s), 1477 (s), 1443 (s), 1410 (s), 1385 (m), 1346 (s), 1331
8.78 (s, 1 H, NCHN) ppm. 13C NMR (100 MHz, CD2Cl2): δ =
(s), 1310 (vs), 1292 (s), 1223 (m), 1177 (s), 1123 (vs), 1111 (vs),
24.9, 25.5 (NCH2CH2), 46.9, 50.3 (NCH2), 128.4 (m-CHAr), 130.1 1020 (m), 970 (w), 935 (m), 914 (m), 866 (m), 818 (m), 779 (m),
(o-CHAr), 132.1 (p-CHAr), 137.7 (i-CAr), 157.7 (NCN), 177.5 737 (m), 640 (m), 617 (m), 586 (s), 517 (w), 494 (vs) cm–1. HRMS
(CO) ppm. IR (neat): ν = 3080 (w), 3055 (w), 2963 (w), 2953 (w),
(ESI): m/z calcd. for C10H19N2O+ 183.1492; found 183.1503.
˜
2878 (m), 1632 (s), 1580 (s), 1558 (vs), 1487 (m), 1477 (m), 1464
(m), 1450 (s), 1441 (s), 1344 (s), 1327 (s), 1310 (vs), 1290 (m), 1254
(s), 1244 (s), 1229 (s), 1186 (m), 1153 (s), 1117 (m), 1084 (s), 1063
(s), 1034 (s), 1018 (s), 974 (w), 961 (w), 930 (w), 918 (w), 903 (w),
874 (w), 853 (w), 816 (w), 808 (w), 787 (w), 714 (vs), 687 (s), 646
(m), 617 (w), 581 (w), 563 (w), 542 (w), 530 (w), 521 (w), 505 (w),
498 (w), 486 (m), 474 (s), 463 (s), 451 (vs), 424 (vs) cm–1. HRMS
(ESI): m/z calcd. for C12H15N2O+ 203.1179; found 203.1173.
C12H14N2O (202.26): calcd. C 71.26, H 6.98, N 13.85; found C
71.17, H 7.08, N 13.55.
N-(Morpholinomethylene)benzamide (5i): Obtained from pyrrol-
idine-1-carbonitrile (1a; 0.192 g, 2 mmol) and benzoyl chloride
(0.337 g, 0.24 mmol) according to the general procedure. Pure
product 5i (0.311 g, 1.39 mmol, 70%) was obtained by column
chromatography (diethyl ether/n-pentane, 3:1 + 10% triethylamine)
and HPLC (ethyl acetate/cyclohexane, 8:1) as a colourless solid
(m.p. 100–102 °C). 1H NMR (300 MHz, CD2Cl2): δ = 3.54 (t, 3JH,H
3
= 5 Hz, 2 H, NCH2), 3.73–3.77 [m, 4 H, O(CH2)2], 3.92 (t, JH,H
= 5 Hz, 2 H, NCH2), 7.37–7.45 (m, 2 H, m-CHAr), 7.47–7.53 (m,
1 H, p-CHAr), 8.24 (m, 2 H, o-CHAr), 8.66 (s, 1 H, NCHN) ppm.
13C NMR (75 MHz, CD2Cl2): δ = 44.8, 51.0 (NCH2), 66.7, 67.6
(OCH2), 128.5 (m-CHAr), 130.2 (o-CHAr), 132.4 (p-CHAr), 137.4 (i-
X-ray Crystal Structure Analysis of 5f:[25] C12H14N2O; M = 202.25;
colourless crystal; 0.40ϫ0.20ϫ0.15 mm; a = 9.6827(4), b =
10.7414(6), c = 11.2930(8) Å, β = 114.543(3)°; V = 1068.42(11) Å3;
ρcalc = 1.257 gcm–3; μ = 0.651 mm–1; empirical absorption correc-
tion (0.780 Յ T Յ 0.908); Z = 4; monoclinic; space group P21/n
(No. 14); λ = 1.54178 Å; T = 223(2) K; ω and φ scans, 6233 reflec-
CAr), 159.9 (NCHN), 177.9 (CO) ppm. IR (neat): ν = 3082 (vw),
˜
3063 (vw), 2988 (vw), 2968 (m), 2932 (w), 2876 (w), 2361 (w), 2330
(vw), 1632 (m), 1582 (s), 1570 (s), 1555 (vs), 1485 (w), 1464 (m),
1441 (m), 1431 (m), 1339 (vs), 1325 (vs), 1310 (s), 1279 (m), 1269
8
www.eurjoc.org
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 0000, 0–0